, Tracking Stock Market Picks
Enter Symbol:
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

up 42.95 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $102 by CRT Capital

Posted on: Tuesday,  Mar 3, 2015  9:25 AM ET by CRT Capital

CRT Capital rated Buy Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on 03/03/2015, when the stock price was $65.93. Since
then, Ligand Pharmaceuticals Incorporated has gained 42.95% as of 09/30/2015's recent price of $94.25.
If you would have followed this CRT Capital's recommendation on LGND, you would have gained 42.95% of your investment in 211 days.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

CRT Capital has consistently provided its clients with creative, idea-driven advice and solutions through targeted research and trading of High-Yield, Distressed, Convertible, and Emerging Market Debt Securities and Equities.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2015 9:25 AM Buy
65.93 102.00
as of 8/27/2015
1 Week up  0.12 %
1 Month down  -5.28 %
3 Months up  12.04 %
1 YTD up  42.95 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy